Fig. 1From: Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case reportTimeline of treatment received and corresponding pelvic magnetic resonance imaging. The Arrow is pointing the cervix tumoral massBack to article page